Skip to content

Analysis of inflammation and fibrosis mechanisms in eosinophilic esophagitis and esophageal motility disorders.

Analysis of inflammation and fibrosis mechanisms in eosinophilic esophagitis and esophageal motility disorders. - Analysis of inflammation and fibrosis mechanisms in eosinophilic esophagitis and esophageal motility disorders.

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000049850
Enrollment
100
Registered
2023-01-01
Start date
2020-01-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Eosinophilic Esophagitis, Esophageal Achalasia, Esophageal Motility Disorder

Interventions

None listed

Sponsors

Chiba University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients with eosinophilic esophagitis or esophageal motility disorders 2. Patients who are aged 20 years or older at the time of acquisition 3. Patients who agree to participate this study after receiving an explanation and providing consent forms

Exclusion criteria

Exclusion criteria: 1. Patients who refused to participate in this study 2. Patients judged to be ineligible by the research director

Design outcomes

Primary

MeasureTime frame
Correlation of clinical information with the phenotype of T cells in tissues and blood in cases of eosinophilic esophagitis and esophageal motility disorders

Countries

Japan

Contacts

Public ContactTatsuya Kaneko

Chiba University Hospital Gastroenterology

kanekota@chiba-u.jp043-222-7171

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026